Tate & Lyle (TATE) AI Stock Analysis

• Market Cap: £1.66B
• Dividend Yield: 5.27%
• Average Volume (3M): 2.61M
• Price to Earnings (P/E): 49.0
• Beta (1Y): 0.80
• Revenue Growth: 26.84%
• EPS Growth: -81.73%
• Country: UK
• Employees: 3,318
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Packaged Foods
• EPS (TTM): 0.21
• Shares Outstanding: 445,446,780
• 10 Day Avg. Volume: 2,809,626
• 30 Day Avg. Volume: 2,611,880
• PEG Ratio: -0.61
• Price to Book (P/B): 4.01
• Price to Sales (P/S): 3.67
• P/FCF Ratio: 148.36
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: £425.52
• Price Target Upside: 15.95% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 5
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 65 Neutral
• Price Target: 401.00p ▲(9.26% Upside)

Tate & Lyle's overall stock score reflects stable financial performance and positive corporate events, such as insider share purchases. However, technical indicators and valuation suggest caution, with high P/E ratios and neutral momentum. Earnings call insights highlight current market challenges, balancing the positive aspects.

Positive Factors

CP Kelco Merger Success

The successful integration and cross-selling opportunities from the CP Kelco merger enhance Tate & Lyle's market reach and growth potential, indicating a strategic advantage that can drive long-term revenue growth.

Strong Sucralose Demand

Consistent strong demand for sucralose supports stable revenue streams and highlights Tate & Lyle's competitive position in the sweeteners market, contributing to sustained business performance.

Productivity Program on Track

Effective execution of the productivity program ensures operational efficiency, cost savings, and margin improvement, strengthening Tate & Lyle's financial health and competitiveness.

Negative Factors

Revenue and EBITDA Decline

Anticipated declines in revenue and EBITDA reflect challenging market conditions, which may pressure financial performance and limit growth opportunities in the near to medium term.

Challenging Market Conditions

Difficult market conditions, especially in key regions like North America, can impede sales growth and profitability, posing risks to Tate & Lyle's business stability and expansion efforts.

Impact of Tariffs

Tariff impacts can disrupt supply chains and increase costs, potentially eroding margins and affecting Tate & Lyle's competitive positioning in affected markets.

Tate & Lyle Business Overview & Revenue Model

Company Description

Tate & Lyle PLC, together with its subsidiaries, provides ingredients and solutions to the food, beverage, and other industries in the United States, the United Kingdom, other European countries, and internationally. It operates through three segments: Food & Beverage Solutions, Sucralose, and Primary Products. The company offers texturants; nutritive sweeteners, such as high fructose corn syrup and dextrose; health and wellness ingredients; and stabilizers. It also provides industrial starches for paper, packaging, and industrial adhesives; acidulants, such as citric acid; and commodities comprising corn gluten feed and meal for animal nutrition, as well as corn oil and ethanol. In addition, the company engages in the treasury and insurance businesses; and provision of research and development services. Tate & Lyle PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.

How the Company Makes Money

Tate & Lyle generates revenue primarily through the sale of its specialty ingredients and solutions to the food and beverage industry. Key revenue streams include the production and sale of sweeteners, such as high-fructose corn syrup and sucralose, as well as texturants that improve food texture and stability. The company also benefits from long-term contracts with major food manufacturers, ensuring a consistent revenue flow. Additionally, Tate & Lyle engages in partnerships and collaborations with other companies to innovate and expand its product offerings, contributing to its earnings. Global demand for healthier and more sustainable food options further drives the company's growth, as it aligns its product development with market trends and consumer preferences.

Tate & Lyle Financial Statement Overview

Summary

Tate & Lyle demonstrates stable financial performance with consistent revenue growth and solid profitability margins. The balance sheet shows prudent leverage management, though there are areas for improvement in cash flow consistency and return on equity.

Income Statement

Tate & Lyle has shown a consistent revenue growth with a slight dip in the latest year. The gross profit margin and net profit margin are healthy, although the net profit margin has seen some volatility. EBIT and EBITDA margins indicate stable operational efficiency.

Balance Sheet

The company maintains a moderate debt-to-equity ratio, indicating balanced leverage. The return on equity has been reasonable but slightly declined, suggesting room for improvement in utilizing shareholder funds. The equity ratio is strong, reflecting a solid asset base relative to liabilities.

Cash Flow

Operating cash flow is positive, yet shows fluctuations, affecting free cash flow growth. The company has a stable operating cash flow to net income ratio, demonstrating its ability to convert earnings into cash efficiently.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.99B	1.74B	1.65B	1.75B	1.38B	1.21B
Gross Profit	-69.00M	706.00M	851.00M	733.00M	514.00M	481.00M
EBITDA	254.00M	254.00M	345.00M	279.00M	168.00M	292.00M
Net Income	34.00M	143.00M	188.00M	190.00M	236.00M	253.00M
Balance Sheet
Total Assets	3.60B	3.73B	2.28B	2.51B	3.25B	2.97B
Cash, Cash Equivalents and Short-Term Investments	325.00M	334.00M	437.00M	475.00M	112.00M	371.00M
Total Debt	1.29B	1.31B	590.00M	713.00M	679.00M	786.00M
Total Liabilities	2.05B	2.14B	1.04B	1.32B	1.63B	1.51B
Stockholders Equity	1.55B	1.59B	1.24B	1.19B	1.62B	1.45B
Cash Flow
Free Cash Flow	71.00M	43.00M	98.00M	-12.00M	-45.00M	217.00M
Operating Cash Flow	188.00M	164.00M	208.00M	66.00M	103.00M	369.00M
Investing Cash Flow	-931.00M	-630.00M	-20.00M	835.00M	-113.00M	-205.00M
Financing Cash Flow	452.00M	367.00M	-215.00M	-598.00M	-247.00M	-29.00M

Tate & Lyle Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 367.00
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:TATE, the sentiment is Neutral. The current price of 367 is below the 20-day moving average (MA) of 373.03, below the 50-day MA of 372.70, and below the 200-day MA of 463.53, indicating a neutral trend. The MACD of -0.28 indicates Negative momentum. The RSI at 54.91 is Neutral, neither overbought nor oversold. The STOCH value of 80.34 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:TATE.

Tate & Lyle Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ANP	78 Outperform	£79.32M	15.44	13.81%	2.42%	34.26%	71.40%
ABF	69 Neutral	£13.22B	13.20	9.22%	2.98%	-3.06%	-26.93%
TATE	65 Neutral	£1.66B	48.97	2.48%	5.27%	26.84%	-81.73%
FVA	64 Neutral	£69.89M	20.61	―	3.14%	―	―
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
SALT	45 Neutral	£28.35M	-5.89	-1427.02%	―	147.18%	3.11%

Tate & Lyle Corporate Events

Tate & Lyle Director Increases Stake With ADR Purchase

Tate & Lyle has disclosed that non-executive director Claudia Vaz de Lestapis and a person closely associated with her, Alexandre Samuel Pierre Marie de Lestapis, purchased 5,000 American Depositary Receipts in the company on 6 January 2026 at a price of $19.79 per ADR on the OTCQX exchange. Following this transaction, they now hold 5,000 ADRs, representing 20,000 ordinary shares, a move formally notified under market abuse regulations that signals increased personal investment by a board member in the company’s equity.

The most recent analyst rating on (GB:TATE) stock is a Hold with a £401.00 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.

Tate & Lyle Discloses Year-End ADR Sale by Non-Executive Director

Tate & Lyle has disclosed that non-executive director and person discharging managerial responsibilities (PDMR) Glenn Fish sold 5,000 American Depositary Receipts on 17 December 2025 at a price of US$20.11 per ADR on the OTCQX exchange. The company stated the sale was undertaken for year-end portfolio rebalancing and tax alignment, noting that Fish retains 49.8 ADRs and intends to repurchase ADRs early in 2026, a signal aimed at reassuring investors that the transaction does not reflect reduced confidence in the business.

The most recent analyst rating on (GB:TATE) stock is a Hold with a £401.00 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.

Tate & Lyle CEO Granted Share Options Under Sharesave Plan

Tate & Lyle PLC announced that Nick Hampton, the Chief Executive Officer, has been granted options to purchase 6,043 ordinary shares under the Tate & Lyle Sharesave Plan 2020. This move is part of the company’s strategy to align managerial interests with shareholder value, potentially impacting the company’s operational focus and market positioning.

The most recent analyst rating on (GB:TATE) stock is a Hold with a £401.00 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.

Tate & Lyle Executives Conduct ADR Sale for Portfolio Rebalancing

Tate & Lyle PLC announced that Claudia Vaz de Lestapis, a non-executive director, and Alexandre Samuel Pierre Marie de Lestapis sold 5,000 American Depositary Receipts (ADRs) at a price of $19.80 each, totaling $99,000. This transaction was conducted for year-end portfolio rebalancing and tax alignment purposes, with plans to repurchase ADRs in early 2026. The sale was disclosed in compliance with the Market Abuse Regulation, indicating transparency in the company’s managerial transactions.

The most recent analyst rating on (GB:TATE) stock is a Hold with a £4.10 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.

Tate & Lyle CFO Increases Shareholding, Signaling Confidence

Tate & Lyle PLC announced that Sarah Kuijlaars, the Chief Financial Officer, acquired 15,000 ordinary shares of the company at a price of £3.898 per share, bringing her total holdings to 85,000 shares. This transaction, conducted on the London Stock Exchange, reflects the confidence of the company’s management in its financial health and future prospects, potentially impacting investor sentiment positively.

The most recent analyst rating on (GB:TATE) stock is a Hold with a £400.00 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.

Tate & Lyle CFO Appointed to JD Sports Board

Tate & Lyle PLC announced that its Chief Financial Officer, Sarah Kuijlaars, has been appointed as a non-executive director at JD Sports Fashion Plc, effective from November 10, 2025. This appointment will see her joining the Audit and Risk Committee and the Nomination Committee, and she will become the Chair of the Audit and Risk Committee starting June 1, 2026. This move could enhance Tate & Lyle’s strategic positioning by strengthening its leadership team with broader industry insights, potentially benefiting stakeholders through improved governance and risk management practices.

The most recent analyst rating on (GB:TATE) stock is a Buy with a £500.00 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.

Tate & Lyle Reports Interim Results and Dividend Increase

Tate & Lyle PLC announced its preliminary results for the six months ending 30 September 2025, highlighting an interim dividend of 6.6p per share, up from 6.4p in 2024. The company will host a results presentation led by its CEO and CFO, with a live webcast available for analysts and investors. This announcement reflects Tate & Lyle’s continued commitment to shareholder returns and its strategic growth following the acquisition of CP Kelco, positioning the company as a leader in the food ingredient industry.

The most recent analyst rating on (GB:TATE) stock is a Hold with a £390.00 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.